H81.3 - Other Peripheral Vertigo | ICD-10
H81.3 is the ICD-10 code for other peripheral vertigo. It describes balance disorders originating in the inner ear or the vestibular nerve.
Things worth knowing about "H81.3"
H81.3 is the ICD-10 code for other peripheral vertigo. It describes balance disorders originating in the inner ear or the vestibular nerve.
What is H81.3?
H81.3 is a diagnostic code from the International Classification of Diseases, 10th Revision (ICD-10). It stands for other peripheral vertigo – vestibular disorders that originate in the peripheral balance system but cannot be classified under a more specific ICD-10 subcategory such as Ménière's disease, benign paroxysmal positional vertigo (BPPV), or vestibular neuritis.
Causes and Pathophysiology
Peripheral vertigo arises from dysfunction of the inner ear (labyrinth) or the vestibular nerve, which transmits balance signals to the brain. When the disorder cannot be attributed to a more precisely defined condition, the code H81.3 is used. Potential underlying causes include:
- Inflammatory conditions of the inner ear
- Circulatory disturbances affecting the inner ear
- Toxic damage to the vestibular organ (e.g., caused by medications or chemicals)
- Viral or bacterial infections involving the inner ear
- Age-related degeneration of the vestibular organ
Symptoms
Common symptoms associated with peripheral vertigo classified under H81.3 include:
- Rotational vertigo: The sensation that the surroundings are spinning
- Postural instability: Unsteadiness or swaying when standing or walking
- Nystagmus: Involuntary, rhythmic eye movements
- Balance disturbances and increased risk of falling
- Nausea and vomiting
- Hearing changes or a sensation of pressure in the ear (depending on the underlying cause)
Differentiation from Other H81 Diagnoses
The ICD-10 category H81 covers various vestibular function disorders. The main subcategories are:
- H81.0: Ménière's disease
- H81.1: Benign paroxysmal vertigo (BPPV)
- H81.2: Vestibular neuronitis
- H81.3: Other peripheral vertigo (not elsewhere classified)
- H81.4: Vertigo of central origin
H81.3 is therefore used when peripheral vertigo is confirmed but does not fit any of the more specific subcategories listed above.
Diagnosis
The diagnosis of H81.3 is typically made by an ear, nose and throat (ENT) specialist or a neurologist. Diagnostic procedures may include:
- Medical history: Detailed assessment of the type, duration, and circumstances of the vertigo
- Clinical examination: Evaluation of balance, gait, and eye movements
- Audiometry: Measurement of hearing function
- Vestibular function tests: e.g., caloric irrigation, videonystagmography (VNG)
- Imaging: MRI or CT of the skull to rule out central causes
Treatment
Treatment depends on the underlying cause of the peripheral vertigo. General therapeutic approaches include:
- Pharmacological therapy: Antivertiginous drugs (e.g., betahistine), antiemetics for severe nausea
- Physiotherapy and balance training: Vestibular rehabilitation therapy to improve balance function
- Treatment of the underlying condition: e.g., antiviral or antibiotic therapy for infectious causes
- General measures: Avoiding known triggers, ensuring adequate sleep, and reducing stress
References
- World Health Organization (WHO): International Statistical Classification of Diseases and Related Health Problems, 10th Revision (ICD-10). Geneva: WHO, 2019.
- Strupp M, Dieterich M, Brandt T. The treatment and natural course of peripheral and central vertigo. Deutsches Aerzteblatt International, 2013;110(29-30):505–516.
- Bhattacharyya N et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update). Otolaryngology – Head and Neck Surgery, 2017;156(3_suppl):S1–S47.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryMost read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: H81.3